Linked Data API

Show Search Form

Search Results

540147
registered interest false more like this
date less than 2016-07-19more like thismore than 2016-07-19
answering body
Department for Exiting the European Union more like this
answering dept id 203 more like this
answering dept short name Exiting the European Union remove filter
answering dept sort name Exiting the European Union more like this
hansard heading NHS: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Exiting the European Union, what his policy is on future UK involvement in the Innovative Medicines Initiative. more like this
tabling member constituency Kingston upon Hull North more like this
tabling member printed
Diana Johnson more like this
uin 43441 more like this
answer
answer
is ministerial correction false more like this
date of answer remove filter
answer text <p>The Innovative Medicines Initiative is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA to boost biomedical innovation. The UK remains a member of the EU until our withdrawal is completed. UK researchers can still apply for Horizon 2020 projects. Future involvement will need to be agreed in forthcoming negotiations.</p> more like this
answering member constituency Haltemprice and Howden more like this
answering member printed Mr David Davis more like this
question first answered
less than 2016-07-28T12:25:09.187Zmore like thismore than 2016-07-28T12:25:09.187Z
answering member
373
label Biography information for Sir David Davis more like this
tabling member
1533
label Biography information for Dame Diana Johnson more like this